Journal of the American Academy of Dermatology · 2007
Body dysmorphic disorder symptoms among patients with acne vulgaris.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bowe Whitney P, Leyden James J, Crerand Canice E, Sarwer David B, Margolis David J
Аннотация
BACKGROUND: Acne is one of the most common concerns of patients with body dysmorphic disorder (BDD), a psychiatric condition defined as a preoccupation with a slight or imagined defect in appearance that causes significant disruption in daily functioning.
OBJECTIVE: We sought to screen for BDD symptoms among patients with acne across a spectrum of acne severity.
METHODS: We used a validated self-report questionnaire and an objective assessment of acne severity by a single observer.
RESULTS: Rates of BDD ranged from 14.1% using more stringent criteria to assess acne severity to 21.1% using less stringent criteria. Two-fold increased odds of having BDD was seen in patients requiring systemic isotretinoin therapy.
LIMITATIONS: Cross-sectional study design is a limitation.
CONCLUSION: A significant proportion of patients, regardless of their acne severity at the time of examination, have substantial distress and preoccupation related to their facial appearance.
OBJECTIVE: We sought to screen for BDD symptoms among patients with acne across a spectrum of acne severity.
METHODS: We used a validated self-report questionnaire and an objective assessment of acne severity by a single observer.
RESULTS: Rates of BDD ranged from 14.1% using more stringent criteria to assess acne severity to 21.1% using less stringent criteria. Two-fold increased odds of having BDD was seen in patients requiring systemic isotretinoin therapy.
LIMITATIONS: Cross-sectional study design is a limitation.
CONCLUSION: A significant proportion of patients, regardless of their acne severity at the time of examination, have substantial distress and preoccupation related to their facial appearance.